Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

The committee decided not to approve the drug due to low effectiveness and high risks.

Thyroid disorders significantly affect the well-being of married, urban, non-working individuals in South India.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Monitoring steroid hormones in blood can better detect testosterone doping.

Endogenous neurosteroids may set a baseline mood.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

New therapies for rare skin diseases show promise but need more research.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Baricitinib may not always prevent relapse in alopecia areata.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Patient care should come before profit in medicine.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

We need to study how dissolving microneedles behave in the body to use them for medicine.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

Marine biomaterials show promise for drug delivery and wound healing.